Clinical Trials
80 trialsNCT04752215 2026-02-02
A Study Evaluating Different Doses of BI 765049 When Given Alone and When Given With Ezabenlimab to Patients With Advanced Solid Tumors Expressing the Protein B7-H6 on the Cell Surface
Boehringer Ingelheim
Phase 1 Completed
NCT05165433 2025-12-16
FORTIFY
Akamis Bio
Phase 1 Completed
NCT02592577 2025-12-09
MAGE A10ᶜ⁷⁹⁶T for Advanced NSCLC
Adaptimmune
Phase 1 Completed
NCT02185690 2025-08-21
MEK162
University Health Network, Toronto
Phase 1 Completed
NCT04053283 2025-03-24
STAR
Akamis Bio
Phase 1 Completed
NCT05043714 2025-03-24
NEBULA
Akamis Bio
Phase 1 Completed
NCT05023928 2025-03-12
Tumor Antigen-sensitized DC Vaccine As an Adjuvant Therapy for Esophagus Cancer
Sichuan University
Phase 1 Completed
NCT04870840 2024-10-29
Image-guided Proton Therapy for the Treatment of Locally Advanced Unresectable Head and Neck Cancer
M.D. Anderson Cancer Center
Phase 1 Completed
NCT02834611 2024-05-29
Ceramide NanoLiposome in Patients With Advanced Solid Tumors
Keystone Nano, Inc
Phase 1 Completed
NCT02164461 2024-05-20
Axalimogene Filolisbac (ADXS11-001) High Dose in Women With Human Papillomavirus (HPV) + Cervical Cancer
Advaxis, Inc.
Phase 1 Completed
NCT02867007 2024-04-25
KHK2455 Alone and in Combination With Mogamulizumab in Subjects With Locally Advanced or Metastatic Solid Tumors
Kyowa Kirin Co., Ltd.
Phase 1 Completed
NCT00728390 2024-04-22
A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks
Pfizer
Phase 1 Completed
NCT01421524 2023-12-12
Study of CC-122 to Evaluate the Safety, Tolerability, and Effectiveness for Patients With Advanced Solid Tumors, Non-Hodgkin's Lymphoma, or Multiple Myeloma
Celgene
Phase 1 Completed
NCT04990037 2023-06-29
CAPAFOUR
Cantargia AB
Phase 1 Completed
NCT01061645 2023-05-08
Study of MOC31-PE in Antigen Positive Carcinomas
Oslo University Hospital
Phase 1 Completed
NCT01572493 2023-03-06
Continuous Infusion of rhIL-15 for Adults With Advanced Cancer
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT03420742 2023-01-27
A Phase 1 Drug-Drug Interaction Study Between Brigatinib and the CYP3A Substrate, Midazolam, in Participants With ALK-Positive or ROS1-Positive Solid Tumors
Takeda
Phase 1 Completed
NCT03852511 2022-06-24
FORTITUDE
Akamis Bio
Phase 1 Completed
NCT02935309 2022-05-31
Capecitabine and Lenvatinib With External Radiation in Rectal Adenocarcinoma
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT01644968 2022-05-17
Phase 1 Study of Anti-OX40 in Patients With Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT03985072 2022-02-24
Study With Andes-1537 in Patients With Specific Types of Advanced Solid Tumor
Andes Biotechnologies
Phase 1 Completed
NCT01554410 2022-02-17
Intensity Modulated Radiation Therapy With Cisplatin and Gemcitabine to Treat Locally Advanced Cervical Carcinoma
University of California, San Diego
Phase 1 Completed
NCT02636036 2021-11-09
SPICE
Akamis Bio
Phase 1 Completed
NCT01417546 2021-10-18
NHS-IL12 for Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01353625 2021-10-05
Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies.
Celgene
Phase 1 Completed
NCT04419623 2021-05-12
A Study of TL-895 With Standard Available Treatment Versus Standard Available Treatment for the Treatment of COVID-19 in Patients With Cancer
Telios Pharma, Inc.
Phase 1 Completed
NCT01999972 2020-09-24
A Phase 1b Study Of Axitinib In Combination With Crizotinib In Patients With Advanced Solid Tumors
Pfizer
Phase 1 Completed
NCT02507544 2020-05-21
A Safety and Pharmacokinetic Study of TRX-818 Administered Orally to Patients With Advanced Cancer
TaiRx, Inc.
Phase 1 Completed
NCT01916135 2020-04-27
PET Imaging of Cancer Patients Using [18F]-SKI-249380, a Radiolabeled Dasatinib-Derivative
Memorial Sloan Kettering Cancer Center
Phase 1 Completed
NCT01587703 2020-03-16
A Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects With NUT Midline Carcinoma (NMC) and Other Cancers
GlaxoSmithKline
Phase 1 Completed
NCT00097903 2020-03-12
Trial of Oral Karenitecin in Patients With Solid Tumors and Lung Cancer
BioNumerik Pharmaceuticals, Inc.
Phase 1 Completed
NCT02529995 2020-02-11
AURAChinaPK
AstraZeneca
Phase 1 Completed
NCT01295827 2019-12-13
KEYNOTE-001
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT02300610 2019-08-01
Enzalutamide in Combination With Gemcitabine and Cisplatin in Bladder Cancer
H. Lee Moffitt Cancer Center and Research Institute
Phase 1 Completed
NCT00862355 2019-05-03
Bioequivalence Study of SPARC147609 in Patients With Ovarian Cancer
Sun Pharma Advanced Research Company Limited
Phase 1 Completed
NCT02703298 2019-03-28
Safety and Pharmacokinetic Study of TRX-818 in Asian Solid Tumor Patients
TaiRx, Inc.
Phase 1 Completed
NCT02454478 2019-03-19
Study of Lenvatinib in Combination With Everolimus in Participants With Unresectable Advanced or Metastatic Renal Cell Carcinoma (RCC)
Eisai Inc.
Phase 1 Completed
NCT00283075 2019-01-16
Mouse Cancer Cell-containing Macrobeads in the Treatment of Human Cancer
The Rogosin Institute
Phase 1 Completed
NCT00926640 2018-10-19
A Phase I Study of Belinostat in Combination With Cisplatin and Etoposide in Adults With Small Cell Lung Carcinoma and Other Advanced Cancers
National Institutes of Health Clinical Center (CC)
Phase 1 Completed
NCT01215500 2018-09-12
Dose Escalation of Hypofractionated Radiation Therapy in Patients With Metastatic Cancer
University of Chicago
Phase 1 Completed
NCT02192346 2018-08-17
α-TEA in Advanced Cancer
Providence Health & Services
Phase 1 Completed
NCT00726583 2018-05-17
Phase I Trial of Oral PX-866
Seagen Inc.
Phase 1 Completed
NCT01207323 2018-05-01
A Study of the Safety and Pharmacokinetics (PK) of MEHD7945A in Participants With Locally Advanced or Metastatic Epithelial Tumors
Genentech, Inc.
Phase 1 Completed
NCT00599755 2018-01-16
Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)
Merck Sharp & Dohme LLC
Phase 1 Completed
NCT00654758 2017-11-21
A Phase 1b Study With Volociximab in Combination With Carboplatin and Paclitaxel in First-line, Advanced Non-Small Cell Lung Cancer (NSCLC)
AbbVie
Phase 1 Completed
NCT01671592 2017-09-26
Safety of Labeled Dendritic Cell (DC) Vaccines and Feasibility of Tracking by Magnetic Resonance Imaging (MRI)
University of Pittsburgh
Phase 1 Completed
NCT00513383 2017-03-01
Panitumumab Chemoradiotherapy Chemotherapy for Squamous Cancer of the Head and Neck
Massachusetts General Hospital
Phase 1 Completed
NCT01352884 2016-09-05
Study to Assess the Safety, Tolerability, and Pharmacokinetics of AMP-224 in Patients With Advanced Cancer
MedImmune LLC
Phase 1 Completed
NCT00506051 2016-08-25
ZD6474(Vandetanib) + Alimta Combo Study
Sanofi
Phase 1 Completed
NCT02587819 2016-04-14
Investigation of the Safety and Tolerability of BSCT (Anti-nf-P2X7) 10% Ointment
Biosceptre
Phase 1 Completed